Combining Wellbutrin (Bupropion) with Trintellix (Vortioxetine): Key Cautions
When combining bupropion with vortioxetine, you must reduce the vortioxetine dose by half due to a significant drug-drug interaction—bupropion increases vortioxetine blood levels by approximately 128% through CYP2D6 inhibition 1, 2.
Primary Drug Interaction Concern
Bupropion is a strong CYP2D6 inhibitor, and vortioxetine is metabolized primarily through CYP2D6 1, 3. When co-administered:
- Vortioxetine AUC increases by 128% and Cmax by 114% 2
- This substantially elevates the risk of vortioxetine-related adverse effects
- Dose adjustment is mandatory: Reduce vortioxetine dose by half when starting bupropion 2, 4
The FDA labeling for Wellbutrin explicitly notes that bupropion inhibits CYP2D6 and can increase concentrations of other antidepressants, requiring dose reduction consideration 1.
Serotonin Syndrome Risk
While both medications affect serotonin systems, the risk profile differs:
- Vortioxetine is a serotonin transporter inhibitor with multimodal activity 5
- Bupropion has minimal direct serotonergic activity (primarily dopaminergic/noradrenergic)
- The Trintellix label warns about serotonin syndrome risk but does not specifically list bupropion as a high-risk combination 5
- Serotonin syndrome risk is lower with this combination compared to combining two serotonergic agents, but monitor for symptoms (agitation, confusion, tachycardia, hyperthermia, hyperreflexia)
Seizure Threshold Considerations
Bupropion carries a dose-dependent seizure risk (approximately 0.4% at doses ≤450 mg/day) 1:
- Risk increases with doses >450 mg daily
- Contraindicated in patients with seizure disorders, bulimia, or anorexia nervosa 1
- The combination does not appear to synergistically increase seizure risk, but maintain bupropion ≤450 mg/day maximum
Additional Monitoring Parameters
Blood Pressure: Bupropion can increase blood pressure; monitor before and during treatment 1
Activation/Agitation: Both medications can cause:
- Anxiety, agitation, insomnia (common with bupropion) 1
- Activation of mania/hypomania (both agents) 1, 5
- Screen for bipolar disorder before initiating
Bleeding Risk: Vortioxetine (like other serotonergic agents) increases bleeding risk, particularly with NSAIDs, aspirin, or anticoagulants 5
Sexual Function: Interestingly, this combination may be favorable for sexual function:
- Bupropion has significantly lower rates of sexual dysfunction compared to SSRIs 6
- Vortioxetine has less sexual dysfunction than traditional SSRIs 5, 7
Practical Dosing Algorithm
If patient is on vortioxetine and you're adding bupropion: Reduce vortioxetine dose by 50% (e.g., from 20 mg to 10 mg, or from 10 mg to 5 mg)
If patient is on bupropion and you're adding vortioxetine: Start vortioxetine at 5 mg daily (lower than typical 10 mg starting dose)
Titration: Increase cautiously based on tolerability and response, recognizing that therapeutic vortioxetine levels will be achieved at lower doses
If discontinuing bupropion: Increase vortioxetine dose back to standard therapeutic range over 1-2 weeks after bupropion washout
Common Pitfalls to Avoid
- Failing to adjust vortioxetine dose when adding bupropion—this is the most critical error and can lead to excessive nausea, dizziness, and other adverse effects
- Exceeding bupropion 450 mg/day maximum dose (seizure risk)
- Not monitoring blood pressure with bupropion
- Overlooking screening for bipolar disorder (both agents can trigger mania)
The combination is generally well-tolerated when dosed appropriately 2, 4, and may offer complementary mechanisms for treatment-resistant depression, but the pharmacokinetic interaction requires mandatory dose adjustment.